| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription coregulator activity | 7.47e-03 | 562 | 5 | 2 | GO:0003712 | |
| GeneOntologyMolecularFunction | mRNA binding | 1.12e-02 | 694 | 5 | 2 | GO:0003729 | |
| GeneOntologyMolecularFunction | zinc ion binding | 1.82e-02 | 891 | 5 | 2 | GO:0008270 | |
| GeneOntologyBiologicalProcess | mRNA splicing, via spliceosome | 5.05e-05 | 358 | 5 | 3 | GO:0000398 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 5.05e-05 | 358 | 5 | 3 | GO:0000377 | |
| GeneOntologyBiologicalProcess | mRNA cis splicing, via spliceosome | 5.06e-05 | 47 | 5 | 2 | GO:0045292 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions | 5.22e-05 | 362 | 5 | 3 | GO:0000375 | |
| GeneOntologyBiologicalProcess | mRNA splice site recognition | 6.20e-05 | 52 | 5 | 2 | GO:0006376 | |
| GeneOntologyBiologicalProcess | RNA splicing | 1.38e-04 | 502 | 5 | 3 | GO:0008380 | |
| GeneOntologyBiologicalProcess | mRNA processing | 1.82e-04 | 551 | 5 | 3 | GO:0006397 | |
| GeneOntologyBiologicalProcess | spliceosomal complex assembly | 2.26e-04 | 99 | 5 | 2 | GO:0000245 | |
| GeneOntologyBiologicalProcess | mRNA metabolic process | 8.19e-04 | 917 | 5 | 3 | GO:0016071 | |
| GeneOntologyBiologicalProcess | protein-RNA complex assembly | 1.36e-03 | 244 | 5 | 2 | GO:0022618 | |
| GeneOntologyBiologicalProcess | protein-RNA complex organization | 1.47e-03 | 254 | 5 | 2 | GO:0071826 | |
| GeneOntologyBiologicalProcess | RNA processing | 3.43e-03 | 1500 | 5 | 3 | GO:0006396 | |
| GeneOntologyCellularComponent | U2-type prespliceosome | 6.99e-06 | 18 | 5 | 2 | GO:0071004 | |
| GeneOntologyCellularComponent | prespliceosome | 6.99e-06 | 18 | 5 | 2 | GO:0071010 | |
| GeneOntologyCellularComponent | spliceosomal complex | 1.06e-05 | 215 | 5 | 3 | GO:0005681 | |
| GeneOntologyCellularComponent | U1 snRNP | 2.41e-05 | 33 | 5 | 2 | GO:0005685 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | 8.88e-05 | 1377 | 5 | 4 | GO:0140513 | |
| GeneOntologyCellularComponent | spliceosomal snRNP complex | 2.07e-04 | 96 | 5 | 2 | GO:0097525 | |
| GeneOntologyCellularComponent | U2-type spliceosomal complex | 2.11e-04 | 97 | 5 | 2 | GO:0005684 | |
| GeneOntologyCellularComponent | small nuclear ribonucleoprotein complex | 2.57e-04 | 107 | 5 | 2 | GO:0030532 | |
| GeneOntologyCellularComponent | Sm-like protein family complex | 3.18e-04 | 119 | 5 | 2 | GO:0120114 | |
| GeneOntologyCellularComponent | nuclear body | 7.53e-04 | 903 | 5 | 3 | GO:0016604 | |
| GeneOntologyCellularComponent | ribonucleoprotein complex | 1.70e-03 | 1194 | 5 | 3 | GO:1990904 | |
| Pathway | REACTOME_MRNA_SPLICING | 1.13e-05 | 201 | 4 | 3 | MM15411 | |
| Pathway | REACTOME_MRNA_SPLICING | 1.33e-05 | 212 | 4 | 3 | M14033 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 2.96e-05 | 277 | 4 | 3 | MM15414 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 3.15e-05 | 283 | 4 | 3 | M13087 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | 3.15e-04 | 612 | 4 | 3 | MM15547 | |
| Pathway | KEGG_SPLICEOSOME | 4.77e-04 | 127 | 4 | 2 | M2044 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | 5.19e-04 | 724 | 4 | 3 | M16843 | |
| Pathway | WP_MRNA_PROCESSING | 5.87e-03 | 451 | 4 | 2 | MM15946 | |
| Pubmed | 5.66e-10 | 115 | 5 | 4 | 17332742 | ||
| Pubmed | Dynamic protein-protein interaction wiring of the human spliceosome. | 4.97e-09 | 197 | 5 | 4 | 22365833 | |
| Pubmed | 8.46e-08 | 399 | 5 | 4 | 35987950 | ||
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 1.46e-07 | 457 | 5 | 4 | 32344865 | |
| Pubmed | 1.65e-07 | 5 | 5 | 2 | 9724750 | ||
| Pubmed | 6.33e-07 | 660 | 5 | 4 | 32780723 | ||
| Pubmed | FBP WW domains and the Abl SH3 domain bind to a specific class of proline-rich ligands. | 7.44e-07 | 10 | 5 | 2 | 9171351 | |
| Pubmed | 8.13e-07 | 152 | 5 | 3 | 38360978 | ||
| Pubmed | WW domains provide a platform for the assembly of multiprotein networks. | 8.46e-07 | 154 | 5 | 3 | 16055720 | |
| Pubmed | 9.52e-07 | 731 | 5 | 4 | 29298432 | ||
| Pubmed | 1.09e-06 | 12 | 5 | 2 | 11604498 | ||
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 1.41e-06 | 807 | 5 | 4 | 22681889 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 2.75e-06 | 954 | 5 | 4 | 36373674 | |
| Pubmed | Mammalian splicing factor SF1 interacts with SURP domains of U2 snRNP-associated proteins. | 3.82e-06 | 22 | 5 | 2 | 26420826 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 4.54e-06 | 1082 | 5 | 4 | 38697112 | |
| Pubmed | 4.95e-06 | 25 | 5 | 2 | 15456888 | ||
| Pubmed | 1.73e-05 | 421 | 5 | 3 | 34650049 | ||
| Pubmed | 1.78e-05 | 425 | 5 | 3 | 24999758 | ||
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 2.03e-05 | 444 | 5 | 3 | 34795231 | |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | 2.66e-05 | 486 | 5 | 3 | 30940648 | |
| Pubmed | Affinity purification strategies for proteomic analysis of transcription factor complexes. | 7.66e-05 | 97 | 5 | 2 | 23937658 | |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | 8.35e-05 | 714 | 5 | 3 | 28302793 | |
| Pubmed | 8.47e-05 | 102 | 5 | 2 | 26584622 | ||
| Pubmed | 8.67e-05 | 723 | 5 | 3 | 34133714 | ||
| Pubmed | Endogenous purification reveals GREB1 as a key estrogen receptor regulatory factor. | 1.04e-04 | 113 | 5 | 2 | 23403292 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 1.06e-04 | 774 | 5 | 3 | 15302935 | |
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | 1.38e-04 | 130 | 5 | 2 | 35545047 | |
| Pubmed | 1.91e-04 | 153 | 5 | 2 | 28225217 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | 2.20e-04 | 989 | 5 | 3 | 36424410 | |
| Pubmed | Proteomic analysis of SRm160-containing complexes reveals a conserved association with cohesin. | 2.35e-04 | 170 | 5 | 2 | 16159877 | |
| Pubmed | Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation. | 2.64e-04 | 180 | 5 | 2 | 30110629 | |
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 2.64e-04 | 180 | 5 | 2 | 35198878 | |
| Interaction | SNRPB2 interactions | 1.24e-07 | 255 | 5 | 4 | int:SNRPB2 | |
| Interaction | SF3A2 interactions | 1.63e-07 | 273 | 5 | 4 | int:SF3A2 | |
| Interaction | EWSR1 interactions | 1.82e-07 | 906 | 5 | 5 | int:EWSR1 | |
| Interaction | HNRNPUL1 interactions | 4.46e-07 | 351 | 5 | 4 | int:HNRNPUL1 | |
| Interaction | NUP35 interactions | 9.50e-07 | 424 | 5 | 4 | int:NUP35 | |
| Interaction | WBP4 interactions | 1.53e-06 | 109 | 5 | 3 | int:WBP4 | |
| Interaction | SNRPA interactions | 1.59e-06 | 482 | 5 | 4 | int:SNRPA | |
| Interaction | CWC15 interactions | 2.85e-06 | 134 | 5 | 3 | int:CWC15 | |
| Interaction | SNRNP40 interactions | 4.82e-06 | 637 | 5 | 4 | int:SNRNP40 | |
| Interaction | NUPR1 interactions | 6.36e-06 | 683 | 5 | 4 | int:NUPR1 | |
| Interaction | ALG13 interactions | 7.27e-06 | 183 | 5 | 3 | int:ALG13 | |
| Interaction | HNRNPM interactions | 7.98e-06 | 723 | 5 | 4 | int:HNRNPM | |
| Interaction | TCERG1 interactions | 1.05e-05 | 207 | 5 | 3 | int:TCERG1 | |
| Interaction | EYA4 interactions | 1.70e-05 | 243 | 5 | 3 | int:EYA4 | |
| Interaction | ZC3H18 interactions | 1.72e-05 | 877 | 5 | 4 | int:ZC3H18 | |
| Interaction | PPIE interactions | 2.66e-05 | 282 | 5 | 3 | int:PPIE | |
| Interaction | SMC5 interactions | 2.89e-05 | 1000 | 5 | 4 | int:SMC5 | |
| Interaction | SNRPA1 interactions | 3.19e-05 | 300 | 5 | 3 | int:SNRPA1 | |
| Interaction | CPSF7 interactions | 4.56e-05 | 338 | 5 | 3 | int:CPSF7 | |
| Interaction | SF3B4 interactions | 4.72e-05 | 342 | 5 | 3 | int:SF3B4 | |
| Interaction | WDR77 interactions | 5.55e-05 | 361 | 5 | 3 | int:WDR77 | |
| Interaction | PUF60 interactions | 5.92e-05 | 369 | 5 | 3 | int:PUF60 | |
| Interaction | TLE3 interactions | 6.27e-05 | 376 | 5 | 3 | int:TLE3 | |
| Interaction | MECP2 interactions | 7.86e-05 | 1287 | 5 | 4 | int:MECP2 | |
| Interaction | FSAF1 interactions | 8.67e-05 | 60 | 5 | 2 | int:FSAF1 | |
| Interaction | RNPS1 interactions | 9.02e-05 | 425 | 5 | 3 | int:RNPS1 | |
| Interaction | DDX17 interactions | 9.09e-05 | 426 | 5 | 3 | int:DDX17 | |
| Interaction | SNRPC interactions | 1.00e-04 | 440 | 5 | 3 | int:SNRPC | |
| Interaction | MYCN interactions | 1.01e-04 | 1373 | 5 | 4 | int:MYCN | |
| Interaction | PRPF40A interactions | 1.04e-04 | 446 | 5 | 3 | int:PRPF40A | |
| Interaction | RPA4 interactions | 1.08e-04 | 452 | 5 | 3 | int:RPA4 | |
| Interaction | TRIM31 interactions | 1.10e-04 | 454 | 5 | 3 | int:TRIM31 | |
| Interaction | SF3A1 interactions | 1.22e-04 | 471 | 5 | 3 | int:SF3A1 | |
| Interaction | CEBPB interactions | 1.23e-04 | 1443 | 5 | 4 | int:CEBPB | |
| Interaction | SF3B2 interactions | 1.62e-04 | 517 | 5 | 3 | int:SF3B2 | |
| Interaction | DMRTB1 interactions | 2.13e-04 | 94 | 5 | 2 | int:DMRTB1 | |
| Interaction | DDX39B interactions | 2.16e-04 | 570 | 5 | 3 | int:DDX39B | |
| Interaction | NEIL3 interactions | 2.27e-04 | 97 | 5 | 2 | int:NEIL3 | |
| Interaction | HNRNPF interactions | 2.60e-04 | 607 | 5 | 3 | int:HNRNPF | |
| Interaction | WWOX interactions | 2.86e-04 | 627 | 5 | 3 | int:WWOX | |
| Interaction | HNRNPC interactions | 2.96e-04 | 634 | 5 | 3 | int:HNRNPC | |
| Interaction | ZNF207 interactions | 2.97e-04 | 111 | 5 | 2 | int:ZNF207 | |
| Interaction | BRD7 interactions | 3.00e-04 | 637 | 5 | 3 | int:BRD7 | |
| Interaction | LSM7 interactions | 3.59e-04 | 122 | 5 | 2 | int:LSM7 | |
| Interaction | RBM7 interactions | 3.83e-04 | 126 | 5 | 2 | int:RBM7 | |
| Interaction | NKAP interactions | 4.20e-04 | 132 | 5 | 2 | int:NKAP | |
| Interaction | CUL4B interactions | 4.45e-04 | 728 | 5 | 3 | int:CUL4B | |
| Interaction | MAU2 interactions | 4.46e-04 | 136 | 5 | 2 | int:MAU2 | |
| Interaction | CWC22 interactions | 4.79e-04 | 141 | 5 | 2 | int:CWC22 | |
| Interaction | SCAF4 interactions | 4.79e-04 | 141 | 5 | 2 | int:SCAF4 | |
| Interaction | SNW1 interactions | 4.80e-04 | 747 | 5 | 3 | int:SNW1 | |
| Interaction | FAM168A interactions | 4.86e-04 | 142 | 5 | 2 | int:FAM168A | |
| Interaction | TOX4 interactions | 4.86e-04 | 142 | 5 | 2 | int:TOX4 | |
| Interaction | NCOA1 interactions | 5.14e-04 | 146 | 5 | 2 | int:NCOA1 | |
| Interaction | ELF5 interactions | 5.21e-04 | 147 | 5 | 2 | int:ELF5 | |
| Interaction | ZCCHC8 interactions | 5.71e-04 | 154 | 5 | 2 | int:ZCCHC8 | |
| Interaction | SLU7 interactions | 5.86e-04 | 156 | 5 | 2 | int:SLU7 | |
| Interaction | NCBP3 interactions | 5.86e-04 | 156 | 5 | 2 | int:NCBP3 | |
| Interaction | YLPM1 interactions | 6.17e-04 | 160 | 5 | 2 | int:YLPM1 | |
| Interaction | PRPF38A interactions | 6.24e-04 | 161 | 5 | 2 | int:PRPF38A | |
| Interaction | ZC3H14 interactions | 6.88e-04 | 169 | 5 | 2 | int:ZC3H14 | |
| Interaction | GATA1 interactions | 7.04e-04 | 171 | 5 | 2 | int:GATA1 | |
| Interaction | CPSF2 interactions | 7.20e-04 | 173 | 5 | 2 | int:CPSF2 | |
| Interaction | CRNKL1 interactions | 7.54e-04 | 177 | 5 | 2 | int:CRNKL1 | |
| Interaction | SPEN interactions | 7.62e-04 | 178 | 5 | 2 | int:SPEN | |
| Interaction | PPP1R10 interactions | 7.71e-04 | 179 | 5 | 2 | int:PPP1R10 | |
| Interaction | SREK1 interactions | 8.05e-04 | 183 | 5 | 2 | int:SREK1 | |
| Interaction | EXOSC8 interactions | 8.41e-04 | 187 | 5 | 2 | int:EXOSC8 | |
| Interaction | GATA3 interactions | 8.41e-04 | 187 | 5 | 2 | int:GATA3 | |
| Interaction | PML interactions | 9.22e-04 | 933 | 5 | 3 | int:PML | |
| Interaction | WDR83 interactions | 9.23e-04 | 196 | 5 | 2 | int:WDR83 | |
| Interaction | NSRP1 interactions | 9.32e-04 | 197 | 5 | 2 | int:NSRP1 | |
| Interaction | CTNNBL1 interactions | 9.32e-04 | 197 | 5 | 2 | int:CTNNBL1 | |
| Interaction | HNRNPA1 interactions | 9.57e-04 | 945 | 5 | 3 | int:HNRNPA1 | |
| Interaction | SRSF11 interactions | 9.90e-04 | 203 | 5 | 2 | int:SRSF11 | |
| Interaction | SON interactions | 1.04e-03 | 208 | 5 | 2 | int:SON | |
| Interaction | DDX42 interactions | 1.04e-03 | 208 | 5 | 2 | int:DDX42 | |
| Interaction | MKRN3 interactions | 1.06e-03 | 210 | 5 | 2 | int:MKRN3 | |
| Interaction | THOC1 interactions | 1.06e-03 | 210 | 5 | 2 | int:THOC1 | |
| Interaction | ZC3H11A interactions | 1.11e-03 | 215 | 5 | 2 | int:ZC3H11A | |
| Interaction | THOC2 interactions | 1.15e-03 | 219 | 5 | 2 | int:THOC2 | |
| Interaction | ERG interactions | 1.19e-03 | 223 | 5 | 2 | int:ERG | |
| Interaction | BAG4 interactions | 1.20e-03 | 224 | 5 | 2 | int:BAG4 | |
| Interaction | FIP1L1 interactions | 1.21e-03 | 225 | 5 | 2 | int:FIP1L1 | |
| Interaction | SMU1 interactions | 1.24e-03 | 227 | 5 | 2 | int:SMU1 | |
| Interaction | CDK12 interactions | 1.25e-03 | 228 | 5 | 2 | int:CDK12 | |
| Interaction | ATXN1 interactions | 1.26e-03 | 1039 | 5 | 3 | int:ATXN1 | |
| Interaction | RBM39 interactions | 1.27e-03 | 1042 | 5 | 3 | int:RBM39 | |
| Interaction | AKAP8L interactions | 1.38e-03 | 240 | 5 | 2 | int:AKAP8L | |
| Interaction | MAP1LC3A interactions | 1.39e-03 | 241 | 5 | 2 | int:MAP1LC3A | |
| Interaction | LUC7L interactions | 1.40e-03 | 242 | 5 | 2 | int:LUC7L | |
| Interaction | CHEK2 interactions | 1.50e-03 | 250 | 5 | 2 | int:CHEK2 | |
| Interaction | RBM10 interactions | 1.53e-03 | 253 | 5 | 2 | int:RBM10 | |
| Interaction | CPSF1 interactions | 1.56e-03 | 255 | 5 | 2 | int:CPSF1 | |
| Interaction | BCAS2 interactions | 1.74e-03 | 270 | 5 | 2 | int:BCAS2 | |
| Interaction | SRSF10 interactions | 1.75e-03 | 271 | 5 | 2 | int:SRSF10 | |
| Interaction | TPR interactions | 1.88e-03 | 281 | 5 | 2 | int:TPR | |
| Coexpression | GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_CD4_TCELL_DN | 4.13e-04 | 170 | 5 | 2 | M6747 | |
| Coexpression | GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_UP | 4.52e-04 | 178 | 5 | 2 | M8996 | |
| Coexpression | CYCLIN_D1_UP.V1_UP | 4.99e-04 | 187 | 5 | 2 | M2654 | |
| Coexpression | CYCLIN_D1_KE_.V1_UP | 5.05e-04 | 188 | 5 | 2 | M2648 | |
| Coexpression | GSE43863_NAIVE_VS_LY6C_LOW_CXCR5NEG_CD4_EFF_TCELL_D6_LCMV_DN | 5.54e-04 | 197 | 5 | 2 | M9721 | |
| Coexpression | GSE17721_CPG_VS_GARDIQUIMOD_0.5H_BMDC_DN | 5.71e-04 | 200 | 5 | 2 | M3877 | |
| Coexpression | GSE360_DC_VS_MAC_L_DONOVANI_UP | 5.71e-04 | 200 | 5 | 2 | M5174 | |
| Coexpression | GSE17721_0.5H_VS_4H_PAM3CSK4_BMDC_DN | 5.71e-04 | 200 | 5 | 2 | M4108 | |
| Coexpression | GSE16266_CTRL_VS_HEATSHOCK_AND_LPS_STIM_MEF_DN | 5.71e-04 | 200 | 5 | 2 | M7209 | |
| Coexpression | GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD8_TCELL_UP | 5.71e-04 | 200 | 5 | 2 | M4666 | |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_PROERYTHROBLAST_AGEING | 7.76e-04 | 1144 | 5 | 3 | MM3843 | |
| Coexpression | TABULA_MURIS_SENIS_BROWN_ADIPOSE_TISSUE_MYELOID_CELL_AGEING | 8.20e-04 | 240 | 5 | 2 | MM3678 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_1000 | 9.75e-08 | 843 | 5 | 5 | gudmap_developingGonad_e11.5_testes_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.47e-06 | 498 | 5 | 4 | gudmap_developingGonad_e11.5_testes_k5_1000 | |
| CoexpressionAtlas | DevelopingGonad_P2_testes_emap-30171_k-means-cluster#2_top-relative-expression-ranked_1000 | 4.30e-05 | 349 | 5 | 3 | gudmap_developingGonad_P2_testes_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.44e-04 | 524 | 5 | 3 | gudmap_developingGonad_e12.5_testes_k1_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.51e-04 | 533 | 5 | 3 | gudmap_developingGonad_e11.5_testes and mesonephros_k5_1000 | |
| CoexpressionAtlas | DevelopingGonad_P2_testes_emap-30171_top-relative-expression-ranked_1000 | 5.39e-04 | 819 | 5 | 3 | gudmap_developingGonad_P2_testes_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_top-relative-expression-ranked_1000 | 5.39e-04 | 819 | 5 | 3 | gudmap_developingGonad_e12.5_testes_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_1000 | 5.89e-04 | 844 | 5 | 3 | gudmap_developingGonad_e11.5_testes and mesonephros_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.31e-03 | 246 | 5 | 2 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500_k-means-cluster#3 | 1.40e-03 | 255 | 5 | 2 | Facebase_RNAseq_e10.5_Maxillary Arch_500_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | 1.82e-03 | 1241 | 5 | 3 | facebase_RNAseq_e10.5_MandArch_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.91e-03 | 298 | 5 | 2 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_FloorPlate_2500_K3 | 2.43e-03 | 1371 | 5 | 3 | facebase_RNAseq_e8.5_FloorPlate_2500_K3 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.80e-03 | 362 | 5 | 2 | gudmap_developingGonad_e18.5_testes_1000_k3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | 2.97e-03 | 1468 | 5 | 3 | facebase_RNAseq_e10.5_MandArch_2500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.05e-03 | 378 | 5 | 2 | gudmap_developingGonad_e16.5_testes_1000_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_top-relative-expression-ranked_500 | 3.79e-03 | 422 | 5 | 2 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ testes_emap-6710_k-means-cluster#5_top-relative-expression-ranked_1000 | 3.91e-03 | 429 | 5 | 2 | gudmap_developingGonad_e14.5_ testes_1000_k5 | |
| CoexpressionAtlas | DevelopingKidney_e11.5_metaneph mesench_emap-3843_top-relative-expression-ranked_500 | 3.95e-03 | 431 | 5 | 2 | gudmap_developingKidney_e11.5_metaneph mesench_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 3.96e-03 | 432 | 5 | 2 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | 4.66e-03 | 469 | 5 | 2 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500 | 5.11e-03 | 492 | 5 | 2 | Facebase_RNAseq_e10.5_Maxillary Arch_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | 5.96e-03 | 532 | 5 | 2 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 1.28e-04 | 162 | 5 | 2 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-04 | 194 | 5 | 2 | 66c056232ac216780acf4cc8ea325bd8ed1909c9 | |
| ToppCell | facs-Thymus-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-04 | 194 | 5 | 2 | cda1b197efb199330ea7ab25a7cee22cae22589d | |
| ToppCell | facs-Thymus-nan-3m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-04 | 194 | 5 | 2 | f1661f9f2439fca5c1012c693b0744c4e3b90a9b | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.89e-04 | 197 | 5 | 2 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_4|Classical_Monocyte / Disease condition and Cell class | 1.89e-04 | 197 | 5 | 2 | e666f6580e9a20b5e550f02125706db17eec8510 | |
| ToppCell | megakaryocytic-CD34+_Megakaryoblast|megakaryocytic / Lineage and Cell class | 1.93e-04 | 199 | 5 | 2 | 99a65887d3c8a2cde26693dd74404b101bba9d58 | |
| Computational | Neighborhood of G22P1 | 1.08e-04 | 36 | 5 | 2 | GNF2_G22P1 | |
| Computational | Neighborhood of XRCC5 | 4.74e-04 | 75 | 5 | 2 | GNF2_XRCC5 | |
| Computational | Neighborhood of HDAC1 | 1.02e-03 | 110 | 5 | 2 | GNF2_HDAC1 | |
| Drug | cerous chloride | 5.92e-04 | 177 | 5 | 2 | ctd:C026690 | |
| Drug | Neostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A | 6.67e-04 | 188 | 5 | 2 | 6735_DN | |
| Drug | Laudanosine (R,S) [1699-51-0]; Down 200; 11.2uM; HL60; HG-U133A | 7.10e-04 | 194 | 5 | 2 | 1741_DN | |
| Drug | Trimeprazine tartrate [4330-99-8]; Up 200; 5.4uM; MCF7; HT_HG-U133A | 7.18e-04 | 195 | 5 | 2 | 3478_UP | |
| Drug | Levonordefrin [829-74-3]; Down 200; 21.8uM; MCF7; HT_HG-U133A | 7.32e-04 | 197 | 5 | 2 | 7208_DN | |
| Drug | genistein; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 7.32e-04 | 197 | 5 | 2 | 1015_DN | |
| Drug | 1,1-dimethylbiguanide hydrochloride; Down 200; 0.1uM; MCF7; HG-U133A | 7.32e-04 | 197 | 5 | 2 | 3_DN | |
| Drug | Cortisone [53-06-5]; Down 200; 11uM; MCF7; HT_HG-U133A | 7.32e-04 | 197 | 5 | 2 | 7458_DN | |
| Drug | Hydroxytacrine maleate (R,S) [118909-22-1]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 7.40e-04 | 198 | 5 | 2 | 3292_DN | |
| Drug | Isoconazole [27523-40-6]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 7.47e-04 | 199 | 5 | 2 | 7211_DN | |
| Drug | irinotecan | 8.95e-03 | 703 | 5 | 2 | ctd:C051890 | |
| Drug | 2,3-bis(3'-hydroxybenzyl)butyrolactone | 1.63e-02 | 961 | 5 | 2 | ctd:C029497 | |
| Drug | Succimer | 2.75e-02 | 1264 | 5 | 2 | ctd:D004113 | |
| Drug | Magnetite Nanoparticles | 2.94e-02 | 1310 | 5 | 2 | ctd:D058185 | |
| Drug | Mustard Gas | 3.08e-02 | 1341 | 5 | 2 | ctd:D009151 | |
| Drug | Glucose | 3.43e-02 | 1420 | 5 | 2 | ctd:D005947 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PHGMMPQMMPPMGGP | 81 | O75400 | |
| PQMMPPMGGPPMGQM | 86 | O75400 | |
| PMGGPPMGQMPGMMS | 91 | O75400 | |
| PGMMSSVMPGMMMSH | 101 | O75400 | |
| GSPGMMMSMQGMMGP | 1376 | O00512 | |
| MMPAPHMGGPPMMPM | 91 | P09234 | |
| HMGGPPMMPMMGPPP | 96 | P09234 | |
| PMMPMMGPPPPGMMP | 101 | P09234 | |
| GMRPPMGGHMPMMPG | 121 | P09234 | |
| MGGHMPMMPGPPMMR | 126 | P09234 | |
| MPGMPPVMPGMPPGM | 171 | O43670 | |
| PVMPGMPPGMMPMGG | 176 | O43670 | |
| MPPGMMPMGGMMPPG | 181 | O43670 | |
| GKGMMPPPPMGMMPP | 466 | Q15637 |